Human Immunodeficiency Virus Infection Is Associated With Increased Meningococcal Carriage Acquisition Among First-year Students in 2 South African Universities.
Neisseria meningitidis
Southern Africa
carriage
meningococcus
risk factors
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
received:
30
12
2019
accepted:
30
04
2020
pubmed:
6
5
2020
medline:
8
7
2021
entrez:
6
5
2020
Statut:
ppublish
Résumé
Invasive meningococcal disease clusters occur among university students and may reflect higher carriage prevalence among this population. We aimed to measure meningococcal carriage prevalence, acquisition, and risk factors among first-year university students in South Africa. In summer-autumn 2017, after consenting to participate, we collected oropharyngeal swabs and questionnaires on carriage risk factors and tested students for HIV at 2 universities, during registration week (survey 1) and 6-8 weeks later (survey 2). Meningococci were detected by culture and polymerase chain reaction. We enrolled 2120 students at registration. Mean age was 18.5 years, 59% (1252/2120) were female and 0.8% (16/1984) had HIV. Seventy-eight percent of students returned for survey 2 (1655/2120). Among the cohort, carriage prevalence was 4.7% (77/1655) at registration, increasing to 7.9% (130/1655) at survey 2: 5.0% (83) acquired new carriage, 2.8% (47) had persistent carriage, 1.8% (30) cleared the initial carriage, and 90.3% (1495) remained carriage free. At both surveys, nongenogroupable meningococci predominated, followed by genogroups Y, B, W, and C. On multinomial analysis, risk factors for carriage acquisition included attending nightclubs (adjusted relative risk ratio [aRRR], 2.1; 95% CI, 1.1-4.0), having intimate kissing partners (aRRR, 1.8; 95% CI, 1.1-2.9) and HIV (aRRR, 5.0; 95% CI, 1.1-24.4). Meningococcal carriage among first-year university students increased after 2 months. Sociobehavioral risk factors were associated with increased carriage for all analyses. HIV was associated with carriage acquisition. Until vaccination programs become mandatory in South African universities, data suggest that students with HIV could benefit most from meningococcal vaccination.
Sections du résumé
BACKGROUND
Invasive meningococcal disease clusters occur among university students and may reflect higher carriage prevalence among this population. We aimed to measure meningococcal carriage prevalence, acquisition, and risk factors among first-year university students in South Africa.
METHODS
In summer-autumn 2017, after consenting to participate, we collected oropharyngeal swabs and questionnaires on carriage risk factors and tested students for HIV at 2 universities, during registration week (survey 1) and 6-8 weeks later (survey 2). Meningococci were detected by culture and polymerase chain reaction.
RESULTS
We enrolled 2120 students at registration. Mean age was 18.5 years, 59% (1252/2120) were female and 0.8% (16/1984) had HIV. Seventy-eight percent of students returned for survey 2 (1655/2120). Among the cohort, carriage prevalence was 4.7% (77/1655) at registration, increasing to 7.9% (130/1655) at survey 2: 5.0% (83) acquired new carriage, 2.8% (47) had persistent carriage, 1.8% (30) cleared the initial carriage, and 90.3% (1495) remained carriage free. At both surveys, nongenogroupable meningococci predominated, followed by genogroups Y, B, W, and C. On multinomial analysis, risk factors for carriage acquisition included attending nightclubs (adjusted relative risk ratio [aRRR], 2.1; 95% CI, 1.1-4.0), having intimate kissing partners (aRRR, 1.8; 95% CI, 1.1-2.9) and HIV (aRRR, 5.0; 95% CI, 1.1-24.4).
CONCLUSIONS
Meningococcal carriage among first-year university students increased after 2 months. Sociobehavioral risk factors were associated with increased carriage for all analyses. HIV was associated with carriage acquisition. Until vaccination programs become mandatory in South African universities, data suggest that students with HIV could benefit most from meningococcal vaccination.
Identifiants
pubmed: 32369560
pii: 5830735
doi: 10.1093/cid/ciaa521
pmc: PMC8246797
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28-e38Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
Références
PLoS One. 2012;7(9):e46019
pubmed: 23029368
J Infect Dis. 2015 Oct 15;212(8):1298-307
pubmed: 25858956
PLoS One. 2016 Dec 1;11(12):e0167404
pubmed: 27907129
BMJ. 2000 Mar 25;320(7238):846-9
pubmed: 10731181
Clin Infect Dis. 2020 Feb 14;70(5):814-826
pubmed: 30959526
Biomedica. 2015 Jan-Mar;35(1):138-43
pubmed: 26148043
J Infect. 2016 Jun;72(6):667-677
pubmed: 27018131
Clin Infect Dis. 2013 Jan;56(2):291-9
pubmed: 23024291
MMWR Morb Mortal Wkly Rep. 2017 Dec 15;66(49):1352-1356
pubmed: 29240724
Emerg Infect Dis. 2017 Jun;23(6):1009-1011
pubmed: 28518025
BMC Microbiol. 2017 Feb 21;17(1):40
pubmed: 28222677
PLoS One. 2011 May 05;6(5):e19361
pubmed: 21573213
Clin Infect Dis. 2008 Feb 1;46(3):377-86
pubmed: 18181736
AIDS. 2015 Sep 10;29(14):1837-44
pubmed: 26218599
Int J Infect Dis. 2018 Aug;73:109-117
pubmed: 29997031
MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):72-6
pubmed: 21270745
Vaccine. 2018 Jan 2;36(1):29-35
pubmed: 29183735
Expert Rev Vaccines. 2017 Apr;16(4):313-328
pubmed: 27820969
Clin Infect Dis. 2017 Sep 1;65(5):756-763
pubmed: 28505234
Lancet Glob Health. 2016 Dec;4(12):e989-e995
pubmed: 27855873
Clin Infect Dis. 2019 Jul 18;69(3):495-504
pubmed: 30351372
BMC Infect Dis. 2013 Aug 02;13:363
pubmed: 23914778
J Clin Microbiol. 2012 Mar;50(3):702-8
pubmed: 22170919
S Afr Med J. 2017 Aug 25;107(9):12062
pubmed: 28875873
Infect Immun. 2012 Jul;80(7):2346-53
pubmed: 22508859
MMWR Morb Mortal Wkly Rep. 2016 Nov 04;65(43):1189-1194
pubmed: 27811836
Hum Vaccin Immunother. 2018 May 4;14(5):1070-1074
pubmed: 29584565
AIDS. 2010 Jun 1;24(9):1351-60
pubmed: 20559040
S Afr Med J. 2015 Sep 21;105(8):648-55
pubmed: 26449697
Emerg Infect Dis. 2006 Jun;12(6):950-7
pubmed: 16707051
J Clin Microbiol. 2016 Nov;54(11):2743-2748
pubmed: 27582517
BMC Med. 2015 Dec 09;13:297
pubmed: 26654248
Lancet Infect Dis. 2017 Aug;17(8):867-872
pubmed: 28545721
Hum Vaccin Immunother. 2019;15(4):987-994
pubmed: 30513251